To evaluate the clinical relevance of CYP1B1 and ACSL4 in CRC tumors, we first compared the expression of CYP1B1 and ACSL4 in CRC cancer tissues and adjacent normal tissues. This evidence concerns the gene CYP1B1 and cancer.